Can a smartphone app lift the shame of TB?
NCT ID NCT07742683
First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time
Summary
This study tests whether online mindfulness, digital cognitive behavioral therapy, and an interactive chatbot can reduce stigma and improve mental health in people with tuberculosis. About 496 adults with active TB will be randomly assigned to receive these digital tools alongside standard care or standard care alone. The goal is to see if these interventions can ease the psychological burden of TB and support better health outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Digital psychosocial interventions including online mindfulness, online cognitive behavioral therapy (CBT), and a human-computer interaction mini-program
- What this could lead to
- If effective, this approach could offer a scalable way to reduce stigma and improve mental health and treatment adherence for tuberculosis patients.
- What could go wrong
- The trial is early-stage and results may not generalize beyond the study population. Digital interventions may not suit all patients, and the impact on stigma could be limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE PULMONARY TUBERCULOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a shorter TB regimen transform child care?
- A mobile x-ray van with AI could spot TB before it spreads
- Can exercise and breathing training repair lungs damaged by TB?
- Community-Driven TB screening aims to reach vulnerable immigrants
- Smartphone Check-Ins could boost TB treatment success
- New drug naderin may help patients fight infections during cancer and TB therapy